Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 31 citing Stitt: Impaired Retinal Angiogenesis in Diabetes. (0.10 sec) 

The Maillard reaction in eye diseases


AW Stitt - ANNALS-NEW YORK ACADEMY OF SCIENCES, 2005 - interscience.wiley.com
Abstract: Diabetes and age-related eye disorders remain leading causes of blindness
worldwide. While defined pathogenic mechanisms for many of these diseases remain
elusive, there is increasing evidence that products of the Maillard reaction may play an ...
Cited by 35 - Related articles - BL Direct - All 6 versions

VEGF165b, an endogenous C-terminal splice variant of VEGF, inhibits retinal …


O Konopatskaya, AJ Churchill, SJ Harper, DO Bates, … - Mol Vis, 2006 - molvis.org
Purpose: Hypoxia driven ocular angiogenesis occurs in a range of ischemic retinopathies including
proliferative diabetic retinopathy and retinopathy of prematurity. These conditions are initiated
and sustained by hypoxia dependent vascular endothelial growth factor (VEGF) ...
Cited by 35 - Related articles - Cached - All 3 versions

Receptor for advanced glycation end products is involved in impaired angiogenic …


T Shoji, H Koyama, T Morioka, S Tanaka, A Kizu, K … - Diabetes, 2006 - Am Diabetes Assoc
Angiogenic response is impaired in diabetes. Here, we examined the involvement of receptor
for advanced glycation end products (RAGE) in diabetes-related impairment of angiogenesis
in vivo. Angiogenesis was determined in reconstituted basement membrane protein ( ...
Cited by 27 - Related articles - BL Direct - All 5 versions

RAGE and soluble RAGE: potential therapeutic targets for cardiovascular diseases


H Koyama, H Yamamoto, Y Nishizawa - Molecular Medicine, 2007 - pubmedcentral.nih.gov
Receptor for advanced glycation end-products (RAGE) is known to be involved in microvascular
complications in diabetes. RAGE is also profoundly associated with macrovascular complications
in diabetes through regulation of atherogenesis, angiogenic response, vascular injury, ...
Cited by 29 - Related articles - BL Direct - All 6 versions

[PDF] Advanced glycation and retinal pathology during diabetes


AW Stitt, TM Curtis - Pharmacological Reports, 2005 - rabbit.if-pan.krakow.pl
Abstract: Of all microvascular complications of diabetes mellitus, retinopathy remains the most
common. This disease presents major therapeutic problems for the ophthalmologist and despite
many decades of intense research it still constitutes a major cause of blindness in the ...
Cited by 16 - Related articles - View as HTML - BL Direct - All 10 versions

Galectins: structure, function and therapeutic potential


RY Yang, GA Rabinovich, FT Liu - Expert Reviews in Molecular …, 2008 - Cambridge Univ Press
Galectins are a family of animal lectins that bind b-galactosides. Outside the cell,
galectinsbindtocell-surfaceandextracellularmatrixglycansandtherebyaffecta
varietyofcellularprocesses.However,galectinsarealsodetectableinthecytosol and nucleus, ...
Cited by 17 - Related articles - All 2 versions

[PDF] Inhibition of advanced glycation and absence of galectin-3 prevent blood-retinal …


P Canning, JV Glenn, DK Hsu, FT Liu, TA Gardiner, AW … - Exp Diabetes Res, 2007 - hindawi.com
Breakdown of the inner blood-retinal barrier (iBRB) occurs early in diabetes and is central to
the development of sight-threatening diabetic macular edema (DME) as retinopathy
progresses. In the current study, we examined how advanced glycation end prod- ucts ( ...
Cited by 11 - Related articles - View as HTML - All 15 versions

In vitro assays of angiogenesis for assessment of angiogenic and anti-angiogenic …

- nih.gov
AM Goodwin - Microvascular research, 2007 - Elsevier
Blood vessels, either in insufficient numbers or in excess, contribute to the pathogenesis of many
diseases. Agents that stimulate angiogenesis can improve blood flow in patients with ischemic
diseases, whereas anti-angiogenic agents are used to treat disorders ranging from ...
Cited by 13 - Related articles - All 4 versions

Confocal Raman microscopy can quantify advanced glycation end product (AGE) …

- fasebj.org
JV Glenn, JR Beattie, L Barrett, N Frizzell, SR Thorpe, … - The FASEB Journal, 2007 - FASEB
The modification of proteins by nonenzymatic glycation leading to accumulation of advanced
glycation end products (AGEs) is a well-established phenomenon of aging. In the eyes of elderly
patients, these adducts have been observed in retinal pigment epithelium (RPE), ...
Cited by 9 - Related articles - BL Direct - All 5 versions

AGEs mediated expression and secretion of TNF alpha in rat retinal microglia

- bjmu.edu.cn [PDF] 
AL Wang, ACH Yu, QH He, XA Zhu, MOM Tso - Experimental eye research, 2007 - Elsevier
Diabetic retinopathy induces an inflammatory response in the retina characterized by an increase
in inflammatory cytokines and the activation of microglia. The degree of microglia activation may
influence the extent of retina injury following retinal metabolic stress. We have previously ...
Cited by 8 - Related articles - All 4 versions


Result Page: 

1

2

3

4

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google